Nicotinic Receptors and the Treatment of Attentional and Cognitive Deficits in Neuropsychiatric Disorders: Focus on the 7 Nicotinic Acetylcholine Receptor as a Promising Drug Target for Schizophrenia

By  

Central Nervous System Agents in Medicinal Chemistry (Formerly Current Medicinal Chemistry - Central Nervous System Agents), Vol. 7, Iss. 4, 2007-12 ,pp. : 269-288

Bentham Science Publishers

Access to resources Recommend Favorite

Obstacles and Opportunities for Cholinergic Drug Development in the Treatment of Cognitive Disorders

By  

Current Pharmaceutical Design, Vol. 22, Iss. 14, 2016-04 ,pp. : 1981-1985

Bentham Science Publishers

Access to resources Recommend Favorite

Nicotinic Receptors as Therapeutic Targets for Drug Addictive Disorders

By  

CNS & Neurological Disorders - Drug Targets (Formerly Current Drug Targets - CNS & Neurological Disorders), Vol. 12, Iss. 5, 2013-08 ,pp. : 633-640

Bentham Science Publishers

Access to resources Recommend Favorite

Drug Therapy for Patients with Eating Disorders

By  

Current Drug Targets-CNS & Neurological Disorders, Vol. 2, Iss. 1, 2003-02 ,pp. : 17-29

Bentham Science Publishers

Access to resources Recommend Favorite

Nicotinic Treatment for Cognitive Dysfunction

By  

Current Drug Targets-CNS & Neurological Disorders, Vol. 1, Iss. 4, 2002-08 ,pp. : 423-431

Bentham Science Publishers

Access to resources Recommend Favorite